Delivery Order SPE2DE24D0013-SPE2D626F94E0
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $3,400 firm fixed-price delivery order (XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, with an ultimate completion date of November 25, 2025. This delivery order was issued under an existing Indefinite Delivery Contract vehicle and carries no set-aside designation. The award represents a routine procurement action for molecular diagnostic supplies, consistent with Cepheid's established...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $5,440 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 19, 2025. This delivery order, designated XPRS4PLEX-10, represents a non-set-aside procurement executed under Cepheid's established contracting relationship with the federal healthcare and defense procurement system. The award...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $40,800 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents a task order under an existing Indefinite Delivery Contract vehicle. The contract is structured to procure molecular diagnostic reagents and test kits,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,024 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 13, 2026. This delivery order, designated XPRSTREPA-10 (4570410034), carries no set-aside designation and represents procurement of diagnostic testing supplies and reagents from Cepheid's established federal product portfolio....
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,720 by the Defense Logistics Agency Medical Supply Chain on December 17, 2025, with an ultimate completion date of December 24, 2025. This delivery order, designated XPRS4PLEX-10, is issued under an Indefinite Delivery Contract framework and carries no set-aside designation. The contract calls for the delivery of diagnostic reagents and test kits designed for Cepheid's GeneXpert...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,840.00 under contract XPRSTREPA-10 by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued on December 23, 2025, with an ultimate completion date of December 31, 2025, represents a task order under an existing Indefinite Delivery Contract vehicle. The award is for diagnostic reagents and test kits designed for Cepheid's GeneXpert diagnostic platform,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $6,800 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents a task order issued under Cepheid's broader contracting relationship with the federal healthcare system. The company's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,040 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 19, 2025. This delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents a supply order for diagnostic reagents and test kits under Cepheid's existing contract vehicle. The award reflects Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, received a firm fixed-price delivery order valued at $36,482.40 from the Defense Logistics Agency Medical Supply Chain on January 5, 2026. This delivery order, designated XPRSMVP-10, represents a non-set-aside procurement with an ultimate completion date of January 12, 2026. The award is associated with Cepheid's established role as a primary federal supplier of advanced molecular diagnostic systems and reagents,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a delivery order valued at $2,765.04 by the Defense Logistics Agency Medical Supply Chain on January 7, 2026, with ultimate completion by January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, requires no set-aside designation and is being performed at Cepheid's Sunnyvale headquarters. The contract falls under the company's established relationship with the Defense...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F94E0Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $20,400 firm fixed-price delivery order from the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with an ultimate completion date of January 15, 2026. This delivery order, designated XPRS4PLEX-10, is a child contract with no set-aside designation and will be performed in Sunnyvale, California. The award represents a procurement of diagnostic testing supplies and reagents, specifically XPRS4PLEX-10 cartridges designed for Cepheid's GeneXpert diagnostic platform, which enables rapid molecular detection of infectious diseases and respiratory pathogens. This delivery order falls under Cepheid's established relationship with the Defense Logistics Agency Medical Supply Chain, which has issued numerous procurement actions for diagnostic testing supplies and reagent kits to support federal healthcare operations. The award reflects Cepheid's position as a primary federal supplier of molecular diagnostic solutions across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and Defense Logistics Agency. The firm fixed-price structure and compressed timeline for this modest-value order demonstrate the demand-driven procurement model through which federal health agencies maintain critical diagnostic capabilities for infectious disease testing and clinical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 1/7/26 |